The Cancer Prevention and Control Program (CPC) is a longstanding component of the University of Arizona Cancer Center that is characterized by its highly collaborative, multidisciplinary team science designed to reduce cancer rates and related burden. The scientific goal of the CPC is to develop and implement highly interactive cancer prevention and control research that will lead to progressive reductions in cancer incidence, morbidity, and mortality. The Cancer Prevention and Control Program is led by H-H. Sherry Chow, PhD, and Cynthia Thomson, PhD, RDN, leaders who support our cancer prevention scientists in who collectively conduct translational research that spans from the laboratory to the clinic to the community.

The CPC fosters high impact multidisciplinary and translational science that serves the University of Arizona Cancer Center catchment area. Scientific goals are accomplished with integration of faculty from across the campus of the University of Arizona and are operationalized through cancer-site or theme specific team science. 

The Program Members’ research aims focus on three major themes:

To advance understanding of, and implement strategies to modify, factors associated with cancer risk.

To evaluate novel therapeutic prevention strategies that will impact cancer prevention. 


To design and test behavioral and psychosocial interventions to improve cancer outcomes. 

Program Goals

  • The CPC will conduct translational research to identify biological, genetic, environmental, and lifestyle risk factors, and related interactions, associated with cancer risk while developing and/or testing strategies for risk reduction.
  • The CPC will conduct laboratory, translational, and clinical research studies to identify potential targets for cancer prevention and to evaluate therapeutic prevention strategies, including pharmaceuticals, nutraceuticals, and vaccines for cancer prevention.
  • The CPC will conduct behavioral and psychosocial research to develop and test interventions to improve health behaviors, quality of life, symptom management and cancer outcomes in cancer survivors.

These aims represent key thematic areas of research that work in synergy to advance scientific knowledge and Program impact. Researchers operationalize their efforts through interdisciplinary teams organized by cancer type or theme and include women’s cancers (breast, ovarian), colorectal cancer, prostate cancer, liver cancer and skin cancer. Studies are designed to integrate cutting-edge research activities across the continuum of cancer prevention and control and to address special populations and cancer burdens in the catchment area.